peptides

  • EBV EBNA3  406-414, LEKARGSTY

    EBV EBNA3 406-414, LEKARGSTY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LEKARGSTY-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA3  458-466, YPLHEQHGM

    EBV EBNA3 458-466, YPLHEQHGM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YPLHEQHGM-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA3  577-584, SVRDRLARL

    EBV EBNA3 577-584, SVRDRLARL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Arthritis, Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SVRDRLARL-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA4  217-225, TYSAGIVQI

    EBV EBNA4 217-225, TYSAGIVQI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TYSAGIVQI-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA4  243-253, RRARSLSAERY

    EBV EBNA4 243-253, RRARSLSAERY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RRARSLSAERY-OH Specifications: 11mer peptide as TFA salt

  • EBV EBNA4  279-287, VSFIEFVGW

    EBV EBNA4 279-287, VSFIEFVGW

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VSFIEFVGW-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA4  488-496, AVLLHEESM

    EBV EBNA4 488-496, AVLLHEESM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-AVLLHEESM-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA4  657-666, VEITPYKPTW

    EBV EBNA4 657-666, VEITPYKPTW

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VEITPYKPTW-OH Specifications: 10mer peptide as TFA salt

  • EBV EBNA6  163-171, EGGVGWRHW

    EBV EBNA6 163-171, EGGVGWRHW

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-EGGVGWRHW-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA6  249-258, LRGKWQRRYR

    EBV EBNA6 249-258, LRGKWQRRYR

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LRGKWQRRYR-OH Specifications: 10mer peptide as TFA salt

  • EBV EBNA6  343-351, FRKAQIQGL

    EBV EBNA6 343-351, FRKAQIQGL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FRKAQIQGL-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA6  958-965, QPRAPIRPI

    EBV EBNA6 958-965, QPRAPIRPI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-QPRAPIRPI-OH Specifications: 9mer peptide as TFA salt

  • EBV EBNA6 284-293 Peptide (HLA-A2) - LLDFVRFMGV

    EBV EBNA6 284-293 Peptide (HLA-A2) – LLDFVRFMGV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Burkitt’s lymphoma, Hodgkin’s lymphoma, Infectious mononucleosis, Nasopharyngeal carcinoma Layout: Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Epstein-Barr nuclear antigen (EBNA) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LLDFVRFMGV-OH Specifications: 10mer peptide as TFA salt

  • EBV Latent membrane protein 1  51-59, ALLVLYSFA

    EBV Latent membrane protein 1 51-59, ALLVLYSFA

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ALLVLYSFA-OH Specifications: 9mer peptide as TFA salt

  • EBV Latent membrane protein 2  329-337, LLWTLVVLL

    EBV Latent membrane protein 2 329-337, LLWTLVVLL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Arthritis, Infection, Infectious mononucleosis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LLWTLVVLL-OH Specifications: 9mer peptide as TFA salt

  • EBV Latent membrane protein 2  340-350, SSCSSCPLSKI

    EBV Latent membrane protein 2 340-350, SSCSSCPLSKI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Epstein-Barr Virus (EBV) Protein Name: Latent membrane protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SSCSSCPLSKI-OH Specifications: 11mer peptide as TFA salt